USPTO trademark

RELINIFY

Under examinationUSPTOWord markClass 5

"RELINIFY" is a word mark owned by Takeda Pharmaceuticals U.S.A., Inc., filed at the USPTO on September 17, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Takeda Pharmaceuticals U.S.A., Inc. portfolioGet this data via the API
Official USPTO record
RELINIFY trademark as filed
As filed with the USPTO
Status
Under examination
Since September 17, 2026
Filed
September 17, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50114329
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns RELINIFY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Takeda Pharmaceuticals U.S.A., Inc.

Cambridge, United States

145 trademarks in the portfolioView company

Representative

Karl M. Zielaznicki

Troutman Pepper Locke LLP

Goods and services

What the mark covers

The products and services RELINIFY is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application office supplied data entered
  3. New application entered
FAQ

About RELINIFY

Who owns the trademark "RELINIFY"?

The USPTO trademark "RELINIFY" (application 50114329) is owned by Takeda Pharmaceuticals U.S.A., Inc.

What is the status of "RELINIFY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RELINIFY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0b4a2-1c68-7456-9f63-a7a7d618d909
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0b4a2-1c68-7456-9f63-a7a7d618d909",
  "object": "trademark",
  "mark_text": "RELINIFY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50114329",
  "filing_date": "2026-09-17",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Takeda Pharmaceuticals U.S.A., Inc.",
      "entity_id": "ent_019fce7c-12dc-743a-89ee-bd4f02052511"
    }
  ]
}